Ulipristal Pregnancy and Breastfeeding Warnings
Ulipristal is also known as: ella
Ulipristal Pregnancy Warnings
Animal studies have failed to reveal evidence of teratogenicity; however, the drug has an embryolethality effect in animals. There are no controlled data in human pregnancy. US FDA pregnancy category X: Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
Use is contraindicated. US FDA pregnancy category: X Comments: After drug treatment, use of a reliable non-hormonal barrier method of contraception is recommended until the next menstrual period starts.
Ulipristal Breastfeeding Warnings
Ella(R) and ellaOne(R): During the week after drug treatment, breastfeeding is not recommended and patients are advised to express and discard breast milk in order to stimulate lactation.
SEVERITY: MAJOR LEVEL 1: Ella(R) and ellaOne(R): Use is not recommended. Esmya(R): Use is contraindicated. Excreted into human milk: Yes Comments: The effects in the nursing infant are unknown.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.